Accuray Incorporated (ARAY) - Total Assets
Based on the latest financial reports, Accuray Incorporated (ARAY) holds total assets worth $447.60 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check ARAY cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Accuray Incorporated - Total Assets Trend (2002–2025)
This chart illustrates how Accuray Incorporated's total assets have evolved over time, based on quarterly financial data. Explore ARAY long-term investment intensity to see how much of total assets are deployed in long-term investments.
Accuray Incorporated - Asset Composition Analysis
Current Asset Composition (June 2025)
Accuray Incorporated's total assets of $447.60 Million consist of 67.5% current assets and 32.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 12.2% |
| Accounts Receivable | $97.87 Million | 20.8% |
| Inventory | $141.02 Million | 30.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $15.00K | 0.0% |
| Goodwill | $57.80 Million | 12.3% |
Asset Composition Trend (2002–2025)
This chart illustrates how Accuray Incorporated's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Accuray Incorporated.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Accuray Incorporated's current assets represent 67.5% of total assets in 2025, an increase from 17.3% in 2002.
- Cash Position: Cash and equivalents constituted 12.2% of total assets in 2025, down from 17.3% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, an increase from 0.0% in 2002.
- Asset Diversification: The largest asset category is inventory at 30.0% of total assets.
Accuray Incorporated Competitors by Total Assets
Key competitors of Accuray Incorporated based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Dirui Industrial Co Ltd
SHE:300396
|
China | CN¥2.62 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
Accuray Incorporated - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.42 | 1.64 | 1.83 |
| Quick Ratio | 0.66 | 0.92 | 1.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $87.37 Million | $130.03 Million | $160.41 Million |
Accuray Incorporated - Advanced Valuation Insights
This section examines the relationship between Accuray Incorporated's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.08 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | 0.3% |
| Total Assets | $470.24 Million |
| Market Capitalization | $34.30 Million USD |
Valuation Analysis
Below Book Valuation: The market values Accuray Incorporated's assets below their book value (0.07x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Accuray Incorporated's assets grew by 0.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Accuray Incorporated (2002–2025)
The table below shows the annual total assets of Accuray Incorporated from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $470.24 Million | +0.34% |
| 2024-06-30 | $468.63 Million | -2.21% |
| 2023-06-30 | $479.21 Million | +1.35% |
| 2022-06-30 | $472.85 Million | -1.51% |
| 2021-06-30 | $480.10 Million | -2.21% |
| 2020-06-30 | $490.93 Million | +12.04% |
| 2019-06-30 | $438.18 Million | +15.70% |
| 2018-06-30 | $378.73 Million | -6.82% |
| 2017-06-30 | $406.46 Million | -13.34% |
| 2016-06-30 | $469.03 Million | -0.20% |
| 2015-06-30 | $469.97 Million | -5.09% |
| 2014-06-30 | $495.19 Million | +4.05% |
| 2013-06-30 | $475.93 Million | +0.58% |
| 2012-06-30 | $473.17 Million | +3.81% |
| 2011-06-30 | $455.78 Million | +73.18% |
| 2010-06-30 | $263.18 Million | -4.08% |
| 2009-06-30 | $274.39 Million | -6.99% |
| 2008-06-30 | $295.00 Million | -11.17% |
| 2007-06-30 | $332.11 Million | +139.58% |
| 2006-06-30 | $138.62 Million | +59.59% |
| 2005-06-30 | $86.86 Million | +168.53% |
| 2003-06-30 | $32.35 Million | +171.25% |
| 2002-06-30 | $11.93 Million | -- |
About Accuray Incorporated
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation t… Read more